Theratechnologies Inc. (TH)

Currency in CAD
4.33
+0.03(+0.70%)
Closed·
Trading near 52-week High
Fair Value
Day's Range
4.334.34
52 wk Range
1.584.34
Key Statistics
Bid/Ask
4.32 / 4.36
Prev. Close
4.3
Open
4.33
Day's Range
4.33-4.34
52 wk Range
1.58-4.34
Volume
1.9K
Average Volume (3m)
5.33K
1-Year Change
114.36%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Theratechnologies Inc. News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Theratechnologies Inc. Company Profile

Theratechnologies Inc., a biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its product pipeline includes tesamorelin F8 in HIV-associated lipodystrophy that is in Phase 2 clinical trials for the treatment of nonalcoholic steatohepatitis; SORT1+ Technology that is in Phase 1 clinical trials for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; sudocetaxel zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company also commercializes olezarsen, an RNA-targeted medicine for the treatment of familial chylomicronemia syndrome and severe hypertriglyceridemia; and donidalorsen, an RNA-targeted medicine that targets the acute attacks of hereditary angioedema. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Compare TH to Peers and Sector

Metrics to compare
TH
Peers
Sector
Relationship
P/E Ratio
0.0x0.0x0.0x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.0x0.0x
Price / LTM Sales
0.0x0.0x0.0x
Upside (Analyst Target)
0.0%0.0%0.0%
Fair Value Upside
Unlock0.0%0.0%Unlock

Earnings

Latest Release
Oct 11, 2023
EPS / Forecast
-- / -0.07
Revenue / Forecast
-- / 21.83M
EPS Revisions
Last 90 days

TH Income Statement

People Also Watch

16.63
SES
+0.85%
18.76
LSPD
+4.75%
11.210
ACHR
+2.00%
15.01
VLN
+0.13%
161.810
BBDb
+0.83%

FAQ

What Stock Exchange Does Theratechnologies Inc. Trade On?

Theratechnologies Inc. is listed and trades on the CBOE Canada Exchange stock exchange.

What Is the Stock Symbol for Theratechnologies Inc.?

The stock symbol for Theratechnologies Inc. is "TH."

What Is the Theratechnologies Inc. Market Cap?

As of today, Theratechnologies Inc. market cap is 199.09M.

What Is Theratechnologies Inc.'s Earnings Per Share (TTM)?

The Theratechnologies Inc. EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is TH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Theratechnologies Inc. Stock Split?

Theratechnologies Inc. has split 0 times.

What is the current trading status of Theratechnologies Inc. (TH)?

As of 27 Jul 2025, Theratechnologies Inc. (TH) is trading at a price of 4.33, with a previous close of 4.30. The stock has fluctuated within a day range of 4.33 to 4.34, while its 52-week range spans from 1.58 to 4.34.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.